Clinical and Genetic Markers of Nonalcoholic Fatty Liver Disease and Prediction of Liver Disease Mortality: Ready for Population Screening?

Gastroenterology. 2020 May;158(6):1838-1840. doi: 10.1053/j.gastro.2020.03.022. Epub 2020 Mar 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Fibrosis
  • Genetic Markers
  • Humans
  • Liver
  • Non-alcoholic Fatty Liver Disease*
  • Phospholipases

Substances

  • Genetic Markers
  • Phospholipases